4//SEC Filing
HERMAN JOAN E 4
Accession 0000874015-25-000281
CIK 0000874015other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 5:12 PM ET
Size
13.3 KB
Accession
0000874015-25-000281
Insider Transaction Report
Form 4
HERMAN JOAN E
Director
Transactions
- Exercise/Conversion
Common Stock
2025-11-19$40.05/sh+12,000$480,600→ 58,086 total - Sale
Common Stock
2025-11-19$72.13/sh−12,000$865,590→ 46,086 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-11-19−32,000→ 0 totalExercise: $63.90From: 2020-06-10Exp: 2029-06-08→ Common Stock (32,000 underlying) - Exercise/Conversion
Common Stock
2025-11-19$63.90/sh+32,000$2,044,800→ 78,086 total - Sale
Common Stock
2025-11-19$72.13/sh−32,000$2,308,240→ 46,086 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-11-19−12,000→ 0 totalExercise: $40.05From: 2022-07-01Exp: 2031-06-30→ Common Stock (12,000 underlying)
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.985 to $72.33 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) on this Form 4.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001248398
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 5:12 PM ET
- Size
- 13.3 KB